FI70416C - Foerfarande foer framstaellning av en injektabel chondroitin polysulfat - Google Patents

Foerfarande foer framstaellning av en injektabel chondroitin polysulfat Download PDF

Info

Publication number
FI70416C
FI70416C FI821651A FI821651A FI70416C FI 70416 C FI70416 C FI 70416C FI 821651 A FI821651 A FI 821651A FI 821651 A FI821651 A FI 821651A FI 70416 C FI70416 C FI 70416C
Authority
FI
Finland
Prior art keywords
chondroitin
methanol
liters
solution
carried out
Prior art date
Application number
FI821651A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI821651A0 (fi
FI821651L (fi
FI70416B (fi
Inventor
Karl Helmut Wolf
Original Assignee
Luitpold Werk Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Werk Chem Pharm filed Critical Luitpold Werk Chem Pharm
Publication of FI821651A0 publication Critical patent/FI821651A0/fi
Publication of FI821651L publication Critical patent/FI821651L/fi
Application granted granted Critical
Publication of FI70416B publication Critical patent/FI70416B/fi
Publication of FI70416C publication Critical patent/FI70416C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI821651A 1981-05-11 1982-05-11 Foerfarande foer framstaellning av en injektabel chondroitin polysulfat FI70416C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3118588A DE3118588C2 (de) 1981-05-11 1981-05-11 Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
DE3118588 1981-05-11

Publications (4)

Publication Number Publication Date
FI821651A0 FI821651A0 (fi) 1982-05-11
FI821651L FI821651L (fi) 1982-11-12
FI70416B FI70416B (fi) 1986-03-27
FI70416C true FI70416C (fi) 1986-09-19

Family

ID=6131969

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821651A FI70416C (fi) 1981-05-11 1982-05-11 Foerfarande foer framstaellning av en injektabel chondroitin polysulfat

Country Status (19)

Country Link
US (1) US4524066A (fr)
JP (1) JPS57192401A (fr)
AT (1) AT387225B (fr)
AU (1) AU552545B2 (fr)
BE (1) BE893097A (fr)
CA (1) CA1207758A (fr)
CH (1) CH650788A5 (fr)
DE (1) DE3118588C2 (fr)
DK (1) DK160317C (fr)
FI (1) FI70416C (fr)
FR (1) FR2505185B1 (fr)
GB (1) GB2098232B (fr)
IE (1) IE53633B1 (fr)
IL (1) IL65743A (fr)
IT (1) IT1157939B (fr)
LU (1) LU84143A1 (fr)
NL (1) NL186638C (fr)
NO (1) NO157147C (fr)
SE (1) SE458118B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
CA1327354C (fr) * 1987-03-19 1994-03-01 David Cullis-Hill Composes et compositions anti-inflamatoires
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5519010A (en) * 1989-02-06 1996-05-21 Taiho Pharmaceutical Co., Ltd. Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component
ATE138938T1 (de) * 1989-02-06 1996-06-15 Taiho Pharmaceutical Co Ltd Sulfatiertes polysaccharid, dessen pharmazeutisch verträgliche salze, dessen herstellung und medikament, das dieses als wirksstoff enthält
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
JPH05279381A (ja) * 1991-09-13 1993-10-26 Dainippon Ink & Chem Inc 硫酸化オリゴ糖芳香族配糖体
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US5591724A (en) * 1995-02-14 1997-01-07 Bioniche Inc. Method for treating the urinary bladder and associated structures using hyaluronic acid
IN181358B (fr) * 1995-02-14 1998-05-30 Bioniche Inc
WO2000056298A2 (fr) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Traitement de la maladie de la lyme au moyen de formulations de glycosaminoglycans polysulfates
SI1625135T1 (sl) * 2003-02-27 2009-08-31 Glaxo Group Ltd Sestavek natrijevega fondaparinuksa visoke äśistote
JP4679138B2 (ja) * 2004-12-24 2011-04-27 株式会社日本バリアフリー 高純度化されたムコ多糖類の製造方法
FR2969618B1 (fr) * 2010-12-28 2014-05-16 Pf Medicament Procede de preparation de chondroitine sulfate de sodium
RU2677330C2 (ru) * 2015-11-20 2019-01-16 Закрытое Акционерное Общество "Фармфирма "Сотекс" Способ приготовления инъекционной формы препарата хондроитина сульфата
WO2024072942A2 (fr) 2022-09-29 2024-04-04 Adora Animal Health Corporation Formulations pénétrant dans la peau de glycosaminoglycanes sulfatés et fragments dérivés de celles-ci pour le traitement de la douleur et d'autres états médicaux

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136572C (fr) * 1902-12-05
DE870094C (de) * 1950-10-17 1953-03-09 Geigy Ag J R Verfahren zur Herstellung von Polyschwefelsaeureestern des Chondroitins
DE935843C (de) * 1951-07-12 1955-12-01 Hoffmann La Roche Verfahren zur Herstellung eines blutgerinnungshemmenden Mittels
US2767167A (en) * 1953-07-06 1956-10-16 Gen Mills Inc Process of reducing the viscosity of gums
DE968752C (de) * 1954-01-29 1958-03-27 Hoffmann La Roche Verfahren zur Herstellung von Chondroitinpolyschwefelsaeureestern
US2803558A (en) * 1956-06-27 1957-08-20 Commw Color & Chemical Co Method of treating adhesive gums
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
US3174904A (en) * 1963-03-25 1965-03-23 Rexall Drug Chemical Method of purifying sulfated carbohydrates
US3405120A (en) * 1966-01-27 1968-10-08 Green Cross Corp Low molecular chondroitin sulfate and method for manufacturing the same
US3454560A (en) * 1966-03-01 1969-07-08 Seikagaku Kogyo Co Ltd Process for the production of chondroitin polysulfate
BE857389A (fr) * 1977-08-02 1977-12-01 Marbex Finance Ltd Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000

Also Published As

Publication number Publication date
AT387225B (de) 1988-12-27
DK160317B (da) 1991-02-25
FR2505185A1 (fr) 1982-11-12
DK160317C (da) 1991-08-05
FR2505185B1 (fr) 1986-02-28
SE458118B (sv) 1989-02-27
SE8202947L (sv) 1982-11-12
IT8221189A0 (it) 1982-05-11
NL186638B (nl) 1990-08-16
GB2098232A (en) 1982-11-17
CA1207758A (fr) 1986-07-15
FI821651A0 (fi) 1982-05-11
JPS57192401A (en) 1982-11-26
ATA184282A (de) 1988-05-15
IT1157939B (it) 1987-02-18
US4524066A (en) 1985-06-18
AU552545B2 (en) 1986-06-05
NO157147C (no) 1988-01-27
NO157147B (no) 1987-10-19
CH650788A5 (de) 1985-08-15
DE3118588C2 (de) 1983-07-07
IL65743A (en) 1985-09-29
NL186638C (nl) 1991-01-16
IL65743A0 (en) 1982-08-31
DE3118588A1 (de) 1982-12-02
SE8202947D0 (sv) 1982-05-11
GB2098232B (en) 1985-02-13
AU8357382A (en) 1982-11-18
DK211882A (da) 1982-11-12
JPH0261482B2 (fr) 1990-12-20
LU84143A1 (fr) 1982-09-13
FI821651L (fi) 1982-11-12
NO821551L (no) 1982-11-12
FI70416B (fi) 1986-03-27
NL8201873A (nl) 1982-12-01
IE821127L (en) 1982-11-11
IE53633B1 (en) 1989-01-04
BE893097A (fr) 1982-08-30

Similar Documents

Publication Publication Date Title
FI70416B (fi) Foerfarande foer framstaellning av en injektabel chondroitin polysulfat
EP0265865B1 (fr) Substitut du sang
DE3102621C2 (fr)
DE3240174C2 (fr)
EP0447585B2 (fr) Procédé de production d'une préparation tolérante d'immunoglobuline G intraveineuse
DE2646854A1 (de) Substanz zur verwendung als blutersatz oder blutstrecker, makromolekulare, wasserloesliche verbindung sowie verfahren zur herstellung eines wasserloeslichen makromolekularen produkts, insbesondere als das sauerstofftransportmaterial in einem blutersatz oder blutstrecker
JPH0231081B2 (fr)
DE3228502A1 (de) Verfahren zur herstellung des c1-inaktivators und seine verwendung
EP1294385B1 (fr) Procede de fabrication de porteurs d'oxygene artificiels a partir d'hemoglobines reticulees de maniere covalente ayant des proprietes fonctionnelles ameliorees par reticulation en presence d'effecteurs de l'affinite a l'oxygene de l'hemoglobine, ne reagissant pas chimiquement
DE3150318C2 (de) "Verfahren zur Herstellung eines Polysaccharidderivats des Fibrinolysins"
SK5272002A3 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
DE3422518A1 (de) Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
JP2006291028A (ja) 低分子ヘパリンまたはその塩、ならびにその製造方法
US4379086A (en) Method of preparing immunoglobulin suitable for intravenous administration using PEG
DE69026513T2 (de) Polyhämoglobin durch purinderivate und glutathion stabilisiert
KR0184260B1 (ko) 항트롬보 활성을 지닌 황산화 글리코스아미노글리큐로난
DE3244214A1 (de) Verfahren zur reinigung und fraktionierung von heparin
EP1921091B1 (fr) Procédé pour la préparation d'esters de diacéréine avec de l'acide hyaluronique et préparation pharmaceutiques les contenant
US20020010152A1 (en) Composition consisting of heparin fractions having reproducible characteristics with average molecular weight equal to 5200d
JPS63235301A (ja) ヘパリノイド活性を有する多糖体及びその製造方法並びにそれを含有する抗血液凝固剤
RU1748324C (ru) Способ получения препарата стрептодеказы
CN118105339A (zh) 一种舒更葡糖钠注射液的组成及其制备方法
JPS6143361B2 (fr)
DE4115910A1 (de) Verfahren zur herstellung von nativem, intravenoes verabreichbarem, stabilisiertem immunglobulin
DE1492047B (de) Verfahren zur Gewinnung eines Poly peptids mit immunisierender Wirkung

Legal Events

Date Code Title Description
MA Patent expired

Owner name: LUITPOLD PHARMACEUTICALS, INC.